Ampio Pharmaceuticals, Inc. (AMPE)
NYSEAMERICAN: AMPE · IEX Real-Time Price · USD
0.163
-0.009 (-4.96%)
At close: May 25, 2022 4:00 PM
0.155
-0.008 (-5.092%)
After-hours:May 25, 2022 7:34 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 - 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0.05 | Upgrade |
| Revenue Growth (YoY) | - | - | - | - | - | - | - | - | 0.00% | - | Upgrade |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0.05 | Upgrade |
| Selling, General & Admin | 8.67 | 6.66 | 5.95 | 4.36 | 5.26 | 6.54 | 9.06 | 8.96 | 7.48 | 5.83 | Upgrade |
| Research & Development | 11.9 | 9.17 | 12.62 | 6.83 | 10.42 | 10.55 | 15.11 | 22.49 | 16.6 | 6.04 | Upgrade |
| Operating Expenses | 20.57 | 15.83 | 18.58 | 11.18 | 15.68 | 17.08 | 24.17 | 31.45 | 24.07 | 11.87 | Upgrade |
| Operating Income | -20.57 | -15.83 | -18.58 | -11.18 | -15.68 | -17.08 | -24.17 | -31.45 | -24.02 | -11.82 | Upgrade |
| Interest Expense / Income | 0 | 0 | 0 | 0.01 | -0 | 0 | 0 | 0 | -0.01 | 0 | Upgrade |
| Other Expense / Income | -3.5 | 0.06 | -4.95 | -45.18 | 36.22 | 2.08 | -0.06 | -0.14 | -0 | -0.23 | Upgrade |
| Pretax Income | -17.08 | -15.89 | -13.63 | 33.99 | -51.89 | -19.16 | -24.11 | -31.31 | -24.01 | -11.59 | Upgrade |
| Net Income | -17.08 | -15.89 | -13.63 | 33.99 | -51.89 | -19.16 | -24.11 | -31.31 | -24.01 | -11.59 | Upgrade |
| Net Income Common | -17.08 | -15.89 | -13.63 | 33.99 | -51.89 | -19.16 | -24.11 | -31.31 | -24.01 | -11.59 | Upgrade |
| Shares Outstanding (Basic) | 199 | 173 | 131 | 73 | 65 | 54 | 52 | 50 | 38 | 34 | Upgrade |
| Shares Outstanding (Diluted) | 205 | 173 | 131 | 91 | 65 | 54 | 52 | 50 | 38 | 34 | Upgrade |
| Shares Change | 18.58% | 31.81% | 43.96% | 39.50% | 21.43% | 3.43% | 3.52% | 31.16% | 12.68% | - | Upgrade |
| EPS (Basic) | -0.09 | -0.09 | -0.10 | 0.46 | -0.79 | -0.36 | -0.62 | -0.76 | -0.63 | -0.34 | Upgrade |
| EPS (Diluted) | -0.10 | -0.09 | -0.14 | -0.12 | -0.79 | -0.36 | -0.62 | -0.76 | -0.63 | -0.34 | Upgrade |
| Free Cash Flow Per Share | -0.07 | -0.09 | -0.12 | -0.17 | -0.18 | -0.27 | -0.51 | -0.79 | -0.53 | -0.29 | Upgrade |
| Gross Margin | - | - | - | - | - | - | - | - | 100.00% | 100.00% | Upgrade |
| Operating Margin | - | - | - | - | - | - | - | - | -48047.75% | -23641.51% | Upgrade |
| Profit Margin | - | - | - | - | - | - | - | - | -48017.12% | -23186.09% | Upgrade |
| Free Cash Flow Margin | - | - | - | - | - | - | - | - | -40889.08% | -19430.33% | Upgrade |
| EBITDA | -15.98 | -14.72 | -12.36 | 35.27 | -50.68 | -17.95 | -23.28 | -30.96 | -23.88 | -11.53 | Upgrade |
| EBITDA Margin | - | - | - | - | - | - | - | - | -47766.33% | -23061.30% | Upgrade |
| EBIT | -17.08 | -15.89 | -13.63 | 33.99 | -51.9 | -19.16 | -24.11 | -31.31 | -24.02 | -11.59 | Upgrade |
| EBIT Margin | - | - | - | - | - | - | - | - | -48041.69% | -23186.09% | Upgrade |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).